Print

IAVI 010

This trial tests the safety and immunogenicity of a clade A HIV-DNA/MVA prime-boost combination, in HIV-uninfected healthy volunteers at low risk for HIV infection. In addition, the effect of the route of administration of the MVA boost will be studied.

Trial Details:

IIa Completed
International AIDS Vaccine Initiative (IAVI) April 19, 2003
DNA.HIVA ,MVA.HIVA Pox Gag A; DNA Gag A
DNA.HIVA DNA
MVA.HIVA Viral Vector - Pox
Kenya, United Kingdom 115
http://www.oxavi.org